Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

New Psychoactive Substances: A Matter of Time.

Pantano F, Graziano S, Pacifici R, Busardò FP, Pichini S.

Curr Neuropharmacol. 2019;17(9):818-822. doi: 10.2174/1570159X1709190729101751.

PMID:
31577198
2.

Monitoring Prenatal Exposure to Buprenorphine and Methadone.

Di Trana A, La Maida N, Tittarelli R, Huestis MA, Pichini S, Busardò FP, Carlier J.

Ther Drug Monit. 2019 Aug 14. doi: 10.1097/FTD.0000000000000693. [Epub ahead of print]

PMID:
31425444
3.

Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.

Pichini S, Mannocchi G, Berretta P, Zaami S, Pirani F, Pacifici R, Busardò FP.

Ther Drug Monit. 2019 Aug 1. doi: 10.1097/FTD.0000000000000683. [Epub ahead of print]

PMID:
31389860
4.

The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances.

Zaami S, Busardò FP, Pichini S, Pacifici R, Marinelli E.

Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6008-6010. doi: 10.26355/eurrev_201907_18409. No abstract available.

5.

A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone.

Pellegrini M, Bolino G, Varì MR, Giorgetti R, Pichini S, Busardò FP.

Drug Test Anal. 2019 Sep;11(9):1465-1470. doi: 10.1002/dta.2677. Epub 2019 Jul 25. No abstract available.

PMID:
31301212
6.

Monitoring the effects of perinatal cannabis and synthetic cannabinoid exposure.

Carlier J, Huestis MA, Zaami S, Pichini S, Busardò FP.

Ther Drug Monit. 2019 Jun 28. doi: 10.1097/FTD.0000000000000667. [Epub ahead of print]

PMID:
31268967
7.

Novel fast ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) and extraction of ethylglucuronide in meconium samples.

Malaca S, Marchei E, Barceló Martín B, Minutillo A, Pichini S.

Drug Test Anal. 2019 Sep;11(9):1471-1475. doi: 10.1002/dta.2658. Epub 2019 Jun 27. No abstract available.

PMID:
31177632
8.

Miniaturized analytical platform for cocaine detection in oral fluids by MicroNIR/Chemometrics.

Risoluti R, Pichini S, Pacifici R, Materazzi S.

Talanta. 2019 Sep 1;202:546-553. doi: 10.1016/j.talanta.2019.04.081. Epub 2019 May 8.

PMID:
31171220
9.

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology.

Pichini S, Zaami S, Pacifici R, Tagliabracci A, Busardò FP.

Front Pharmacol. 2019 May 21;10:563. doi: 10.3389/fphar.2019.00563. eCollection 2019. No abstract available.

10.

Cannabidiol Adverse Effects and Toxicity.

Huestis MA, Solimini R, Pichini S, Pacifici R, Carlier J, Busardò FP.

Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901.

PMID:
31161980
11.

Metabolic Pathways and Potencies of New Fentanyl Analogs.

Wilde M, Pichini S, Pacifici R, Tagliabracci A, Busardò FP, Auwärter V, Solimini R.

Front Pharmacol. 2019 Apr 5;10:238. doi: 10.3389/fphar.2019.00238. eCollection 2019. Review.

12.

Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair.

Busardò FP, Carlier J, Giorgetti R, Tagliabracci A, Pacifici R, Gottardi M, Pichini S.

Front Chem. 2019 Apr 2;7:184. doi: 10.3389/fchem.2019.00184. eCollection 2019.

13.

THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".

Pacifici R, Pichini S, Pellegrini M, Rotolo MC, Giorgetti R, Tagliabracci A, Busardò FP, Huestis MA.

Clin Chem Lab Med. 2019 Apr 8. pii: /j/cclm.ahead-of-print/cclm-2019-0119/cclm-2019-0119.xml. doi: 10.1515/cclm-2019-0119. [Epub ahead of print]

PMID:
30956228
14.

Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) analysis of psychoactive drugs in oral fluid.

Malaca S, Busardò FP, Gottardi M, Pichini S, Marchei E.

J Pharm Biomed Anal. 2019 Jun 5;170:63-67. doi: 10.1016/j.jpba.2019.02.039. Epub 2019 Mar 16.

PMID:
30904741
15.

Nails Analysis for Drugs Used in the Context of Chemsex: A Pilot Study.

Busardò FP, Gottardi M, Pacifici R, Varì MR, Tini A, Volpe AR, Giorgetti R, Pichini S.

J Anal Toxicol. 2019 Mar 11. pii: bkz009. doi: 10.1093/jat/bkz009. [Epub ahead of print]

PMID:
30855673
16.

Clarifying methodological issues in cannabinoids determination in bronchoalveolar lavages.

Rotolo MC, Pellegrini M, Martucci P, Giacobbe R, De Palma A, Pacifici R, Pichini S, Busardò FP, Bisconti M.

Clin Chem Lab Med. 2019 Mar 26;57(4):e43-e44. doi: 10.1515/cclm-2018-1374. No abstract available.

PMID:
30796843
17.

The issue of psychotropic drug monitoring in sexual assault victims.

Minutillo A, Pichini S, Mortali C, Tittarelli R, Tini A, Busardò FP.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):908-910. doi: 10.26355/eurrev_201902_16973. No abstract available.

18.

Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry.

Pacifici R, Marchei E, Salvatore F, Guandalini L, Busardò FP, Pichini S.

Clin Chem Lab Med. 2019 Jun 26;57(7):e165-e168. doi: 10.1515/cclm-2018-1145. No abstract available.

PMID:
30472696
19.

Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails.

Busardò FP, Gottardi M, Tini A, Mortali C, Giorgetti R, Pichini S.

Molecules. 2018 Oct 18;23(10). pii: E2686. doi: 10.3390/molecules23102686.

20.

Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.

Pacifici R, Pichini S, Pellegrini M, Tittarelli R, Pantano F, Mannocchi G, Rotolo MC, Busardò FP.

Clin Chem Lab Med. 2018 Dec 19;57(2):238-243. doi: 10.1515/cclm-2018-0566.

PMID:
30332386
21.

Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices.

Graziano S, Anzillotti L, Mannocchi G, Pichini S, Busardò FP.

J Pharm Biomed Anal. 2019 Jan 30;163:170-179. doi: 10.1016/j.jpba.2018.10.011. Epub 2018 Oct 4. Review.

PMID:
30316062
22.

Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease.

Rotolo MC, Pellegrini M, Martucci P, Giacobbe R, De Palma A, Pacifici R, Pichini S, Busardò FP, Bisconti M.

Clin Chem Lab Med. 2019 Mar 26;57(4):498-503. doi: 10.1515/cclm-2018-0426.

PMID:
30231009
23.

Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids.

Solimini R, Pichini S, Pacifici R, Busardò FP, Giorgetti R.

Front Pharmacol. 2018 Jun 20;9:654. doi: 10.3389/fphar.2018.00654. eCollection 2018.

24.

Analytical Advances in Clinical and Forensic Toxicology. Second Part.

Pichini S, Busardo FP.

Curr Pharm Biotechnol. 2018;19(2):89-90. doi: 10.2174/138920101902180628100648. No abstract available.

PMID:
29962330
25.

Knowledge of gestational alcohol drinking risks: results from a survey among Italian secondary school students.

Berretta P, Minutillo A, Pichini S, Traverso V, Toth G, Scaravelli G, De Luca R, Da Rin Della Mora R.

Ann Ist Super Sanita. 2018 Apr-Jun;54(2):90-95. doi: 10.4415/ANN_18_02_03.

26.

Considerations regarding the development and validation of chromatographic mass spectrometric methods for GHB analysis in forensic toxicology.

Busardò FP, Pichini S, Giorgetti R.

Forensic Sci Int. 2018 Jul;288:e27-e28. doi: 10.1016/j.forsciint.2018.04.020. Epub 2018 Apr 23. No abstract available.

PMID:
29728270
27.

Segmental Hair Testing of Triazolam to Unmask a Suspected Case of Idiopathic Recurrent Stupor.

Postiglione E, Antelmi E, Moresco M, Pichini S, Pizza F, Plazzi G, Busardò FP.

J Clin Sleep Med. 2018 Apr 15;14(4):697-699. doi: 10.5664/jcsm.7078.

28.

Global Prevalence of Fetal Alcohol Spectrum Disorder in Italy.

Pichini S, Pacifici R, Busardò FP.

JAMA Pediatr. 2018 May 1;172(5):497-498. doi: 10.1001/jamapediatrics.2018.0044. No abstract available.

PMID:
29582047
29.

GHB side effects: The need to clearly document drug dose and administration history.

Busardò FP, Pichini S.

J Forensic Leg Med. 2018 May;56:73-74. doi: 10.1016/j.jflm.2018.03.010. Epub 2018 Mar 10. No abstract available.

PMID:
29533209
30.

The challenge of clinical application of FM2 cannabis oil produced in Italy for the treatment of neuropathic pain.

Pichini S, Pacifici R, Busardò FP, Tagliabracci A, Giorgetti R.

Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):863-865. doi: 10.26355/eurrev_201802_14363. No abstract available.

31.

Editorial: Analytical Advances in Clinical and Forensic Toxicology.

Busardo FP, Pichini S.

Curr Pharm Biotechnol. 2017;18(10):784-785. doi: 10.2174/138920101810180124150401. No abstract available.

PMID:
29457763
32.

Synthetic cathinones related fatalities: an update.

Zaami S, Giorgetti R, Pichini S, Pantano F, Marinelli E, Busardò FP.

Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):268-274. doi: 10.26355/eurrev_201801_14129. Review.

33.

The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report.

Jarque P, Marchei E, Roca A, Gomila I, Pichini S, Busardò FP, Barceló B.

Drug Test Anal. 2018 May;10(5):895-898. doi: 10.1002/dta.2360. Epub 2018 Feb 7. No abstract available.

PMID:
29341494
34.

Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy.

Gomez-Roig MD, Marchei E, Sabra S, Busardò FP, Mastrobattista L, Pichini S, Gratacós E, Garcia-Algar O.

Alcohol. 2018 Mar;67:1-6. doi: 10.1016/j.alcohol.2017.08.010. Epub 2017 Aug 31.

PMID:
29289821
35.

Editorial: Advances and Future Developments in Forensic Toxicology: From Standard Practices to New Psychoactive Substances.

Busardo FP, Pichini S, Peters FT.

Curr Pharm Des. 2017;23(36):5427-5428. doi: 10.2174/1381612824666171214101337. No abstract available.

PMID:
29237370
36.

Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.

Mannucci C, Pichini S, Spagnolo EV, Calapai F, Gangemi S, Navarra M, Calapai G.

Curr Drug Metab. 2018;19(13):1056-1064. doi: 10.2174/1389200219666171207122227. Review.

PMID:
29219048
37.

Comment on "Direct Monitoring of Exogenous γ-Hydroxybutyric Acid in Body Fluids by NMR Spectroscopy": Several Issues to Consider When Quantifying γ-Hydroxybutyric Acid in Biological Matrixes.

Pichini S, Busardò FP.

Anal Chem. 2018 Jan 2;90(1):1044-1045. doi: 10.1021/acs.analchem.7b03450. Epub 2017 Dec 19. No abstract available.

PMID:
29190070
38.

Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry.

Pacifici R, Marchei E, Salvatore F, Guandalini L, Busardò FP, Pichini S.

Clin Chem Lab Med. 2018 Mar 28;56(4):94-96. doi: 10.1515/cclm-2017-0758. No abstract available.

PMID:
29176009
39.

Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis.

Rotolo MC, Klein J, Pacifici R, Busardo FP, Pichini S, Marchei E.

Curr Pharm Biotechnol. 2017;18(10):834-839. doi: 10.2174/1389201018666171122114526.

PMID:
29173161
40.

Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.

Rotolo MC, Graziano S, Pellegrini M, Corlazzoli D, Antinori L, Porcarelli L, Pichini S.

Curr Pharm Biotechnol. 2017;18(10):821-827. doi: 10.2174/1389201018666171122115815.

PMID:
29173160
41.

European Drug Users at Risk from Illicit Fentanyls Mix.

Pichini S, Pacifici R, Marinelli E, Busardò FP.

Front Pharmacol. 2017 Oct 31;8:785. doi: 10.3389/fphar.2017.00785. eCollection 2017. No abstract available.

42.

Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update.

Pichini S, Solimini R, Berretta P, Pacifici R, Busardò FP.

Ther Drug Monit. 2018 Feb;40(1):38-51. doi: 10.1097/FTD.0000000000000465. Review.

PMID:
29120973
43.

Editorial:Cannabis: Neurological Correlates in Abuse and Medical Use.

Pichini S, Busardo FP.

CNS Neurol Disord Drug Targets. 2017;16(5):524-526. doi: 10.2174/187152731605170810115956. No abstract available.

PMID:
28847308
44.

Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.

Busardo FP, Pichini S, Pellegrini M, Montana A, Lo Faro AF, Zaami S, Graziano S.

Curr Neuropharmacol. 2018;16(1):84-96. doi: 10.2174/1570159X15666170828162057. Review.

45.

GHB concentration in breast milk of narcoleptic women treated with sodium oxybate. How important it is to be careful when interpreting values.

Busardò FP, Pichini S.

Sleep Med. 2017 Dec;40:129. doi: 10.1016/j.sleep.2017.07.012. Epub 2017 Jul 26. No abstract available.

PMID:
28821387
46.

Hair testing of GHB: an everlasting issue in forensic toxicology.

Busardò FP, Pichini S, Zaami S, Pacifici R, Kintz P.

Clin Chem Lab Med. 2018 Jan 26;56(2):198-208. doi: 10.1515/cclm-2017-0397. Review.

47.

Intoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate.

Barceló B, Gomila I, Rotolo MC, Marchei E, Kyriakou C, Pichini S, Roset C, Elorza MÁ, Busardò FP.

Int J Legal Med. 2017 Nov;131(6):1543-1553. doi: 10.1007/s00414-017-1648-9. Epub 2017 Jul 15.

PMID:
28710651
48.

Nails in Forensic Toxicology: An Update.

Solimini R, Minutillo A, Kyriakou C, Pichini S, Pacifici R, Busardo FP.

Curr Pharm Des. 2017;23(36):5468-5479. doi: 10.2174/1381612823666170704123126. Review.

PMID:
28677498
49.

Mass spectrometry vs. immunoassay in clinical and forensic toxicology: qui modus in rebus est?

Busardò FP, Pacifici R, Pichini S.

Clin Chem Lab Med. 2017 Aug 28;55(10):e236-e237. doi: 10.1515/cclm-2017-0418. No abstract available.

PMID:
28672772
50.

Method Development in Forensic Toxicology.

Peters FT, Wissenbach DK, Busardo FP, Marchei E, Pichini S.

Curr Pharm Des. 2017;23(36):5455-5467. doi: 10.2174/1381612823666170622113331. Review.

PMID:
28641530

Supplemental Content

Loading ...
Support Center